Warning: Creating default object from empty value in /home/altaywgm/public_html/wp-content/plugins/gaviasframework/redux/redux-framework/inc/class.redux_filesystem.php on line 29
New Indication: FOLFOX for second-line advanced biliary tract cancer - Altai Oncology
  1. Home /
    2. Altai Protocol Library /
  2. New Indication: FOLFOX for second-line advanced biliary tract cancer

Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Search Library Posts Search
Altai Protocol Library

New Indication: FOLFOX for second-line advanced biliary tract cancer

New Indication: FOLFOX for second-line advanced biliary tract cancer
Study:
  • Phase III, open-label, randomized trial (ABC-06)
  • Locally advanced or metastatic biliary tract cancer with progression to CISplatin – gemcitabine
  • FOLFOX-6 vs. active symptom control
Efficacy:
  • FOLFOX group => ORR: 5% and PFS @6 mos: 32%
  • Median OS: 6.2 mos vs. 5.3 mos (HR: 0.69 [0.50-0.97])
Safety:
  • Grade >=3 AEs: fatigue (19% vs. 7%), infection (18% vs. 6%), biliary events (19% vs. 20%), neutropenia (12% vs. 1%)
  •  

Lancet Oncol 2021; 22: 690–701

Lamarca A, et al. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

https://doi.org/10.1016/S1470-2045(21)00027-9

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More